Judge Blocks AG Letitia James from Silencing Pregnancy Centers Supporting Abortion Pill Reversal

Democratic New York Attorney General Letitia James cannot take action against pregnancy centers that promote abortion pill reversal, a federal judge ruled. 

The Thomas More Society sued James on behalf of two pro-life ministries, stating that the attorney general threatened to prosecute them if they shared information about what abortion pill reversal was. 

Read More

Commentary: Republicans Must Stop Retreating on Abortion

While President Joe Biden’s halting performance in the first 2024 presidential debate generated the most significant commentary, it was some of former President Donald Trump’s remarks that raised concerns for pro-life voters. Those remarks ended up foreshadowing the recently proposed Republican platform’s surrender on the abortion issue.

Trump’s first misstep was his contention that “everybody” wanted abortion regulated at the state level. “Fifty-one years ago you had Roe v. Wade,” Trump argued, “and everybody wanted to get it back to the states, everybody, without exception, Democrats, Republicans, liberals, conservatives. Everybody wanted it back… Ronald Reagan wanted it brought back” (emphasis added).

Read More

Supreme Court Tosses Doctors’ Challenge to Abortion Pill

Mifepristone boxes

The Supreme Court sided unanimously Thursday against several doctors and pro-life medical associations who brought a challenge to the abortion pill.

In FDA v. Alliance for Hippocratic Medicine, the Supreme Court held that the doctors do not have standing to challenge the U.S. Food and Drug Administration’s (FDA) decision to roll back safety regulations for the abortion pill. While recognizing the plaintiffs have “sincere legal, moral, ideological, and policy objections to elective abortion and to FDA’s relaxed regulation of mifepristone,” Justice Brett Kavanaugh wrote in the majority rulings that those kind of objections are not enough to show the doctors would be injured by the FDA’s actions, noting the federal courts are “the wrong forum” for addressing their concerns.

Read More

Louisiana Abortion Pill Reclassification Bill Heads to Governor’s Desk

Jeff Landry

The Louisiana state Senate approved a bill on Thursday that would place two abortion pills on the state’s list of controlled dangerous substances, sending the legislation to the governor’s desk for his signature.

The state’s House of Representatives passed the bill on Tuesday, which could make possession of the drugs a crime punishable by jail time or a fine. Surgical and medical abortions are already illegal in the southern state except in extreme cases, meaning it is already difficult to obtain the drugs legally. But now the possession itself without a prescription could get an individual up to five years in prison.

Read More

Supreme Court to Weigh Major Case on Abortion Pill Approval

The Supreme Court announced Wednesday that it is taking on a case regarding the Food and Drug Administration’s approval of the chemical abortion pill mifepristone.

Alliance for Hippocratic Medicine, the American Association of Pro-Life Obstetricians and Gynecologists, the American College of Pediatricians and the Christian Medical & Dental Associations filed a lawsuit against the FDA in November 2022, claiming that the FDA had ignored safety protocols to approve the abortion pill mifepristone. The Supreme Court said this week that it would hear the case, one of the first major abortion cases taken up by the court since overturning Roe v. Wade in June 2022, according to an order list.

Read More

17 Minnesota DFL Legislators Sign Brief Asking Supreme Court to Preserve Access to Abortion Pill

Seventeen Democrat legislators from Minnesota have attached their names to an amicus brief last week that asks the U.S. Supreme Court to overturn an appellate court decision that would roll back the public’s access to mifepristone, an abortion-inducing medication.

The DFLers joined a group of more than 600 Democrat legislators from 49 states in signing onto the brief, which asks the nation’s highest court to reject the Fifth Circuit Court of Appeals’ August ruling in FDA v. Alliance for Hippocratic Medicine that concluded several decisions the FDA took in 2016 to make mifepristone more broadly available to women were illegal.

Read More

Federal Appeals Court Allows Abortion Pill Approval to Stand, with Restrictions

A federal appeals court has allowed the U.S. Food and Drug Administration’s approval of the abortion pill to temporarily stand with some limitations.

The Biden administration appealed and filed an emergency motion with the Fifth Circuit shortly after Northern District of Texas Judge Matthew Kacsmaryk issued a preliminary injunction against the FDA’s approval of the drug on Friday, a decision the administration called “extraordinary and unprecedented.” In a 2-1 ruling issued late Wednesday night, the Fifth Circuit granted in part the motion for a stay pending appeal, narrowing the judge’s ruling to apply only to rules issued by the FDA prior to 2016.

Read More

Abortion Pill Maker Sues Red States over Bans: ‘Impacts the Company’s Bottom Line’

A company behind the manufacturing of a pill used in chemical abortions filed a lawsuit on Wednesday morning challenging state bans on the abortions, The New York Times reported. GenBioPro, which makes the abortion pill mifepristone, filed the lawsuit in a West Virginia federal court to argue that Federal Food and Drug regulations (FDA) take priority over state laws regulating abortion, according to the NYT. The lawsuit argues that the FDA’s approval of the abortion pill trumps state laws and that abortion bans violate the Commerce Clause of the Constitution, which protects interstate commerce.

Read More

Judge Theodore Chuang Rules Women Can Get Abortion Pill Without Doctor Visit

A federal judge agreed Monday to suspend a rule that requires women during the COVID-19 pandemic to visit a hospital, clinic or medical office to obtain an abortion pill.

U.S. District Judge Theodore Chuang, an Obama appointee based in Maryland, concluded that the “in-person requirements” for patients seeking medication abortion care impose a “substantial obstacle” to abortion patients and are likely unconstitutional under the circumstances of the pandemic.

Read More